FDA Brief

Warning letters Drugs

FDA warning letter to

Precision Analitica Integral S.A. de C.V.

High riskIssued Feb 5, 2021Posted Feb 9, 2021Center for Drug Evaluation and Research | CDER

FDA found a Mexican firm's hand sanitizer labeled 75% ethanol actually held 40% ethanol plus 28% methanol, a toxic substitute.

What happened

FDA laboratory-tested a batch of CleanCare nogerm ADVANCED HAND SANITIZER that was offered for import into the United States and was detained and refused admission at the border. The product label said it was made at the firm's Mexico City facility and declared 75% ethyl alcohol, but testing found about 40% ethanol and about 28% methanol. FDA had already told the public about the methanol contamination in August 2020 and placed all of the firm's drugs on import alert 66-78; no recall had been started as of the letter.

What FDA found

  1. The declared active ingredient, ethanol, was replaced in whole or in part with methanol, a dangerous chemical.

    Section 501(d)(2) of the FD&C Act, 21 U.S.C. 351(d)(2)
  2. The swap showed that quality assurance at the facility is not working as required by current good manufacturing practice (CGMP, the set of rules drug makers must follow).

    Section 501(a)(2)(B) of the FD&C Act, 21 U.S.C. 351(a)(2)(B)
  3. The hand sanitizer is a new drug sold without FDA approval and does not meet the conditions for selling without an application.

    Section 505(a) of the FD&C Act, 21 U.S.C. 355(a)
  4. The label says 75% ethanol, but the product held far less and did not disclose the methanol, so the labeling is false or misleading.

    Section 502(a) of the FD&C Act, 21 U.S.C. 352(a)
  5. Methanol is in the product but is not listed as an ingredient on the label.

    Section 502(e)(1)(A) of the FD&C Act, 21 U.S.C. 352(e)(1)(A)
  6. The product is dangerous to health when used as labeled, because methanol can be absorbed through skin and cause serious harm.

    Section 502(j) of the FD&C Act, 21 U.S.C. 352(j)

What FDA wants

FDA asks the firm to respond in writing within 15 working days with an investigation into why it did not test raw material or finished product, a list of raw materials and suppliers, a list and full reconciliation of all US-shipped batches with complete batch records, and details of its supplier qualification program. FDA also strongly recommends hiring a qualified CGMP consultant before making drugs for the US market again.

Who should pay attention

  • brands and distributors that imported or sold this firm's hand sanitizer
  • retailers and consumers who bought hand sanitizer labeled as made by this firm
  • hand sanitizer makers and importers that rely on outside ethanol suppliers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. World Perfumes Inc.

    World Perfumes failed to test drug ingredients for toxic contaminants and had inadequate water, FDA says.

    High risk
  2. RNA Bio/Pharma, Incorporated

    FDA found RNA Bio/Pharma failed to test homeopathic oral liquid drugs for dangerous contaminants and did not validate its water system.

    High risk
  3. Kabana Skin Care LLC

    Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.

    High risk
  4. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk